Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Abdalla Aly's publication output changed over time?
ScholarIQpublication output · 2017–2025
Output grew0% over the shown period — from 1 works in 2017 to 1 in 2025.
1
2
3
3
1
1
201720182019202020232025
What are the most-cited papers on Abdalla Aly?
ScholarIQmost cited works
Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review
Abdalla Aly, Sarah M. Ronnebaum, Dipen Patel, Yunes Doleh, Fernando Benavente
Hepatic Oncology. 202066 CitationsOPEN ACCESS
Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma
Abdalla Aly, Courtney Johnson, Shuo Yang, Marc Botteman, Sumati Rao, Arif Hussain
Journal of Medical Economics. 201947 CitationsOPEN ACCESS
Systematic review and benchmarking of Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) in oncology
Caitlyn T. Solem, Young‐Min Kwon, Ruchit Shah, Abdalla Aly, Marc Botteman
Expert Review of Pharmacoeconomics & Outcomes Research. 201834 Citations
Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer
Abdalla Aly, Ruchit Shah, Kala Hill, Marc Botteman
Future Oncology. 201930 CitationsOPEN ACCESS
Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study
on behalf of the MeMo Study Group, Praveen J. Patel, David Steel, Christoph Hirneiß, John Brazier, Abdalla Aly, Bénédicte Lescrauwaet
Eye. 201825 CitationsOPEN ACCESS
Related on ScholarIQ
Novo Nordisk (United States)
Institution
Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review
Paper
Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma
Paper
Systematic review and benchmarking of Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) in oncology
Paper
Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer
Paper
Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study
Paper